When is vancomycin preferred for continuous ambulatory peritoneal dialysis (CAPD) peritonitis caused by Streptococcus species?

Vancomycin for Streptococcal CAPD Peritonitis

Vancomycin is a reasonable alternative for streptococcal CAPD peritonitis, but first-generation cephalosporins (such as cefazolin) are preferred as first-line therapy due to superior outcomes and lower toxicity risk. 1

First-Line Treatment Preference

• First-generation cephalosporins or vancomycin are both effective for treating streptococcal peritonitis in peritoneal dialysis patients, with cure rates exceeding 85% when administered for approximately 2 weeks 1.
• The majority of streptococcal peritonitis episodes in a large Australian multi-center study were successfully treated with either intraperitoneal vancomycin or first-generation cephalosporins for a median duration of 13 days (interquartile range 8-18 days) 1.
• Initial empiric antibiotic choice (vancomycin versus cephalosporin) did not significantly influence clinical outcomes including relapse rates, catheter removal, or permanent hemodialysis transfer 1.

When Vancomycin Is Preferred

Vancomycin becomes the preferred agent in specific clinical scenarios:

• β-lactam allergy or intolerance: Vancomycin is reasonable as the primary alternative when patients cannot tolerate penicillins or cephalosporins 2.
• Methicillin-resistant organisms: Although streptococci are typically methicillin-susceptible, vancomycin provides broader gram-positive coverage if MRSA or resistant coagulase-negative staphylococci are suspected 2.
• Treatment failure with cephalosporins: If no clinical response occurs after 3-5 days of cefazolin-based therapy, switching to vancomycin-containing regimens is reasonable 3.

Vancomycin Dosing for CAPD Peritonitis

Intraperitoneal Administration

• Loading dose: 1000 mg/L of dialysate for adults 4, 5.
  • In pediatric patients, this dosing can result in excessive levels; 500 mg/L loading dose is more appropriate for children to avoid peak concentrations >50-60 mg/L 6.
• Maintenance dose: 50 mg/L in each dwell after the loading dose 5.
• Route: Intraperitoneal (IP) administration is as effective as intravenous (IV) loading and produces fewer side effects 4.
• Duration: 14 days of treatment is standard 1, 7, 4.

Pharmacokinetic Considerations

• Approximately 60% of an intraperitoneal vancomycin dose is absorbed systemically within 6 hours, achieving serum concentrations around 10 mcg/mL with 30 mg/kg dosing 8.
• Serum and peritoneal vancomycin concentrations equilibrate fully and rapidly regardless of IP versus IV administration 4.
• Current intermittent dosing may lead to underdosing in many patients; continuous dosing with 20 mg/kg loading followed by 50 mg/L maintenance in each dwell optimizes intraperitoneal exposure 5.

Clinical Outcomes

Streptococcal peritonitis has favorable outcomes compared to other organisms:

• Lower relapse rate: 3% versus 15% for other organisms 1.
• Lower catheter removal rate: 10% versus 23% 1.
• Lower permanent hemodialysis transfer rate: 9% versus 18% 1.
• Shorter hospitalization: 5 days versus 6 days 1.
• Overall cure rate: 87% of patients successfully treated without relapse, catheter removal, or death 1.

Important Caveats

• The safety and efficacy of intraperitoneal vancomycin have not been established in adequate and well-controlled trials, though extensive clinical experience supports its use 8.
• Chemical peritonitis syndrome has been reported with intraperitoneal vancomycin during CAPD, presenting as cloudy dialysate with variable abdominal pain and fever; this typically resolves after discontinuation 8.
• Monitoring is essential: Vancomycin trough levels should be obtained at steady state (before the fourth or fifth dose) for serious infections, targeting 15-20 mcg/mL for severe disease 2.
• Nephrotoxicity and ototoxicity risks increase when vancomycin is combined with aminoglycosides; avoid this combination unless treating enterococcal infections requiring synergy 2, 8.

Practical Algorithm

1. For penicillin-susceptible streptococcal CAPD peritonitis: Start with first-generation cephalosporin (e.g., cefazolin) IP for 14 days 1.
2. If β-lactam allergy exists: Use vancomycin IP with 1000 mg/L loading dose (adults) or 500 mg/L (children), then 50 mg/L maintenance 4, 5, 6.
3. If no clinical improvement by day 3-5: Consider switching to vancomycin-based therapy 3.
4. Monitor: Check vancomycin levels on day 5 and adjust dosing to prevent toxicity 5.